Sarepta Therapeutics Investor Relations Material
Latest events
Status Update
Sarepta Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sarepta Therapeutics Inc
Access all reports
Sarepta Therapeutics Inc. is a biopharmaceutical company focused on developing genetic medicines for the treatment of rare diseases. The company specializes in RNA-targeted therapies, gene therapy, and gene editing technologies to address neuromuscular and other genetic disorders. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Sarepta Therapeutics Inc
Q4 2024
Sarepta Therapeutics Inc
Q1 2025
Sarepta Therapeutics Inc
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
SRPT
Country
🇺🇸 United States